Gilead Sciences breaks ground on new manufacturing and technical development site in US
New Bay Area building marks significant progress as part of $32 billion US investment projected to create $43 billion in economic value
New Bay Area building marks significant progress as part of $32 billion US investment projected to create $43 billion in economic value
Phase 1 has a total reactor capacity of 440 kL with 63 reactors
New manufacturing facility in Mebane to produce at least 40 million laboratory pipette tips per week
The $700 million project is part of Roche’s $50 billion investment in US manufacturing, infrastructure and R&D
Collaboration reinforces Boehringer Ingelheim’s expertise in microbial contract development and manufacturing
The new facility will enhance AbbVie’s chemical synthesis capacity to support domestic production of current and next-generation neuroscience, immunology, and oncology medicines
Under an exclusive distribution agreement, Sartorius Stedim Biotech will offer Nanotein’s lead products globally
The partnership aims to co-develop technologies set to revolutionize manufacturing of plasmid DNA (pDNA), a critical raw material for advanced medicines
The expanded partnership includes cGMP manufacturing, technology transfer for both drug substance and product
The facility includes advanced laboratories to monitor market trends, consumer needs, product innovation, and formulation improvements
Subscribe To Our Newsletter & Stay Updated